Contact this trialFirst, we need to learn more about you.
Carmustine Wafers for Brain Tumor
Recruiting2 awardsPhase 2
Detroit, Michigan
This trial is testing if adding GLIADEL to the site of a removed tumor, in addition to radiation treatment within six weeks of surgery, is more effective at preventing cancer recurrence than surgery and radiation alone.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service